News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,605 Results
Type
Article (40449)
Company Profile (264)
Press Release (671884)
Multimedia
Podcasts (71)
Webinars (17)
Section
Business (204481)
Career Advice (2017)
Deals (35479)
Drug Delivery (99)
Drug Development (81242)
Employer Resources (173)
FDA (16315)
Job Trends (14919)
News (345934)
Policy (32684)
Tag
Academia (2558)
Accelerated approval (15)
Adcomms (24)
Allergies (114)
Alliances (49573)
ALS (133)
Alzheimer's disease (1552)
Antibody-drug conjugate (ADC) (216)
Approvals (16411)
Artificial intelligence (391)
Autoimmune disease (66)
Automation (27)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (148)
Biotechnology (175)
Bladder cancer (128)
Brain cancer (45)
Breast cancer (483)
Cancer (3748)
Cardiovascular disease (297)
Career advice (1697)
Career pathing (33)
CAR-T (221)
CDC (42)
Cell therapy (594)
Cervical cancer (31)
Clinical research (68081)
Collaboration (1283)
Company closure (4)
Compensation (910)
Complete response letters (43)
COVID-19 (2677)
CRISPR (70)
C-suite (550)
Cystic fibrosis (128)
Data (4461)
Decentralized trials (2)
Denatured (22)
Depression (93)
Diabetes (416)
Diagnostics (6531)
Digital health (33)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (182)
Drug pricing (154)
Drug shortages (28)
Duchenne muscular dystrophy (191)
Earnings (88759)
Editorial (45)
Employer branding (21)
Employer resources (151)
Events (115257)
Executive appointments (922)
FDA (18704)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1168)
Gene editing (155)
Generative AI (30)
Gene therapy (471)
GLP-1 (861)
Government (4598)
Grass and pollen (5)
Guidances (347)
Healthcare (18855)
HIV (42)
Huntington's disease (34)
IgA nephropathy (59)
Immunology and inflammation (201)
Immuno-oncology (16)
Indications (52)
Infectious disease (2897)
Inflammatory bowel disease (170)
Inflation Reduction Act (13)
Influenza (91)
Intellectual property (184)
Interviews (315)
IPO (16608)
IRA (48)
Job creations (3639)
Job search strategy (1426)
Kidney cancer (15)
Labor market (72)
Layoffs (532)
Leadership (27)
Legal (7937)
Liver cancer (85)
Longevity (11)
Lung cancer (540)
Lymphoma (259)
Machine learning (29)
Management (59)
Manufacturing (572)
MASH (130)
Medical device (13607)
Medtech (13630)
Mergers & acquisitions (19736)
Metabolic disorders (1022)
Multiple sclerosis (131)
NASH (16)
Neurodegenerative disease (195)
Neuropsychiatric disorders (48)
Neuroscience (2494)
NextGen: Class of 2025 (6516)
Non-profit (4493)
Now hiring (58)
Obesity (480)
Opinion (238)
Ovarian cancer (132)
Pain (149)
Pancreatic cancer (165)
Parkinson's disease (225)
Partnered (27)
Patents (399)
Patient recruitment (309)
Peanut (52)
People (58207)
Pharmaceutical (63)
Pharmacy benefit managers (23)
Phase I (21193)
Phase II (29975)
Phase III (22331)
Pipeline (2665)
Policy (242)
Postmarket research (2564)
Preclinical (9018)
Press Release (64)
Prostate cancer (189)
Psychedelics (42)
Radiopharmaceuticals (256)
Rare diseases (591)
Real estate (5936)
Recruiting (69)
Regulatory (23438)
Reports (51)
Research institute (2350)
Resumes & cover letters (351)
Rett syndrome (15)
RNA editing (11)
RSV (66)
Schizophrenia (123)
Series A (191)
Series B (147)
Service/supplier (11)
Sickle cell disease (74)
Special edition (20)
Spinal muscular atrophy (149)
Sponsored (34)
Startups (3599)
State (2)
Stomach cancer (14)
Supply chain (92)
Tariffs (79)
The Weekly (47)
Vaccines (901)
Venture capital (63)
Weight loss (309)
Women's health (54)
Worklife (17)
Date
Today (1)
Last 7 days (683)
Last 30 days (2267)
Last 365 days (30421)
2025 (24502)
2024 (35218)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (726)
Alabama (71)
Alaska (7)
Arizona (267)
Arkansas (13)
Asia (38641)
Australia (6311)
California (9145)
Canada (2814)
China (836)
Colorado (384)
Connecticut (392)
Delaware (254)
Europe (83217)
Florida (1365)
Georgia (296)
Hawaii (2)
Idaho (60)
Illinois (708)
India (45)
Indiana (436)
Iowa (18)
Japan (314)
Kansas (118)
Kentucky (33)
Louisiana (17)
Maine (68)
Maryland (1201)
Massachusetts (6678)
Michigan (280)
Minnesota (527)
Mississippi (4)
Missouri (109)
Montana (29)
Nebraska (25)
Nevada (103)
New Hampshire (71)
New Jersey (2515)
New Mexico (28)
New York (2485)
North Carolina (1246)
North Dakota (8)
Northern California (4239)
Ohio (278)
Oklahoma (20)
Oregon (36)
Pennsylvania (1925)
Puerto Rico (18)
Rhode Island (43)
South America (1099)
South Carolina (48)
South Dakota (1)
Southern California (3518)
Tennessee (146)
Texas (1412)
United States (33164)
Utah (270)
Virginia (219)
Washington D.C. (77)
Washington State (763)
West Virginia (4)
Wisconsin (78)
Wyoming (1)
712,605 Results for "seegene inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seegene Unveils CURECA™ and STAgora™ at ADLM 2025, Advancing the Next Stage of Diagnostics
August 6, 2025
·
5 min read
Press Releases
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
July 2, 2025
·
4 min read
Press Releases
Seegene unveils the world’s first unattended PCR automation, igniting a global diagnostic paradigm shift at ADLM 2025
July 24, 2025
·
5 min read
Press Releases
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
March 20, 2025
·
3 min read
Press Releases
Seegene’s CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
May 2, 2025
·
6 min read
Policy
Seegene obtains ISO45001 certification
Seegene Inc. announced that it has achieved an ISO45001 certification on December 27.
December 27, 2023
·
1 min read
Press Releases
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
April 9, 2025
·
5 min read
Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature
Seegene Inc., a leading South Korean company providing a total solution for PCR molecular diagnostics, unveiled its ‘Open Innovation Program powered by Seegene ' in partnership with Springer Nature, a world-leading provider of services to the research community.
September 4, 2023
·
4 min read
Seegene and UK Health Security Agency convene a summit to collectively realize “a World Free from All Diseases”
Seegene Inc. announced that Prof. Dame Jenny Harries, Chief Executive of the UK Health Security Agency, visited its headquarters located in Seoul Korea, on March 27.
April 8, 2024
·
3 min read
Biotech Beach
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.Company expands presence and support in US market
Seegene Technologies, Inc. announced it will change names and begin doing business as Seegene USA, Inc. , effective Jan. 1, 2023.
January 6, 2023
·
1 min read
1 of 71,261
Next
